A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles Midazolam
Clinical trial NCT06327256 · COMPLETED
Trial details
- NCT number
- NCT06327256
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-09
- Primary completion
- 2024-09-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.